BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  SanBio, Inc. Release: Clinical Trial Involving Regenerative Cell Treatment For Patients With Traumatic Brain Injury Permitted In Japan

  April 6, 2016

   · 

  5 min read
• Drug Development

  MorphoSys AG Initiates Phase 2 Combination Trial Of MOR208 And Lenalidomide In Patients With Relapsed Or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

  April 6, 2016

   · 

  4 min read
• Medivir: Annual Report 2015

  April 6, 2016

   · 

  1 min read
• Business

  BioSilta Acquires Worldwide Rights To CyDisCo Technology From University of Oulu To Produce Proteins With Multi-Industry Applications

  April 6, 2016

   · 

  4 min read
• Bedfont Scientific Continue To Sell To The U.S.A. Business As Usual

  April 6, 2016

   · 

  1 min read
• BioCapital

  Lonza Group To Highlight A New 3D Culture System Reforming Spheroid Culture And Analysis At AACR 2016

  April 6, 2016

   · 

  4 min read
• BioMidwest

  SurModics Announces First Patient Enrolled In IDE Study Of Surveil Drug-Coated Balloon

  April 6, 2016

   · 

  6 min read
• Policy

  Mevion Medical Systems Brings Proton Therapy To Central Florida

  April 6, 2016

   · 

  3 min read
• Business

  Incyte Acquires Rights From Eli Lilly To Develop And Commercialize Ruxolitinib (Jakafi) For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD)

  April 6, 2016

   · 

  4 min read
• Genetown

  Arch Therapeutics Announces Notice Of Allowance For Composition-of-Matter Patent Covering Self-Assembling Peptides

  April 6, 2016

   · 

  4 min read